Log in Start free →
Today’s CSR movers
SRE 4.1 ▲ 1.2
CSX 4.0 ▲ 1.2
AEE 4.0 ▲ 1.2
PCG 4.1 ▲ 1.2
SO 3.1 ▲ 0.8
NKE 3.2 ▼ 0.4
GS 2.4 ▼ 0.8
EIX 2.3 ▼ 0.8
CMCSA 2.3 ▼ 0.8
FOX 2.4 ▼ 1.5
—
—
Health Care · NYSE NYSE · ABT

Abbott Laboratories

$104.49 +$1.45 +1.39% CLOSE 07.27.26 AFTER HOURS $104.70
Convergence score
4.1 / 5.0 STRONG BULLISH
+0.0 vs last report
Overall valuation
Overvalued
Aggregated across multiple horizons
Consensus target (12mo)
$118.95 +13.8%
Range $92.00 — $143.00
Sector
Health Care
NYSE · Tracked daily
Today's snapshot

Where the signals stand.

REPORT 07.27.26
UV Convergence Score
REPORT 07.27.26
4.1
/ 5.0
STRONG BULLISH
Consensus signal A
4.0
Consensus signal B
4.0
Consensus signal D
4.0
Rating trend signal
4.5
Analyst average
4.3
Multi-signal aggregate How CSR works →
Day Range
$103.38 – $105.85
52W Range
$81.97 – $137.49
Volume
9.1M
Avg Vol
13.3M
Mkt Cap
$182B
P/E
33.82
EPS (TTM)
$3.09
Div Yield
2.45%
Beta
0.61
Today's convergence

Convergence score sits at 4.1 with overall valuation reading as overvalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation
Overvalued
CSR direction
STRONG BULLISH
Last close
$104.49
Sector
Health Care
Valuation
Three horizons
UPDATED 07.27.26
Short term
0–3 MO
No target Strong Buy
Medium term
3–12 MO
$119+13.5% Buy
Long term
12–36 MO
$85.79-17.9% Overvalued
Open valuation →
Analysts
Coverage & consensus
4 PANELS
Mean target (12mo)
$118.95 +13.8%
RANGE $92.00 — $143.00
Analyst consensus
Consensus rating Buy
Blended score 4.2 / 5
Analysts tracked 106
Open analysts →
Financials
Key metrics
LATEST
P/E
33.82
EPS (TTM)
$3.09
Mkt Cap
$182B
Div Yield
2.45%
Beta
0.61
52W Range
$81.97 – $137.49
Open financials →
Reports
Login for history

Sign in to view the historical report archive for this stock.

Log in →
Valuation breakdown

Three horizons, one consensus.

UPDATED 07.27.26
Short term
0–3 MO
Strong Buy
Consensus target
No target available

Current analyst consensus rating from Barchart.

Medium term
3–12 MO
Buy
Consensus target
$119 +13.5%
RANGE $92 – $143
$92NOW $104.49$143

12-month analyst consensus target across covering brokerages.

Long term
12–36 MO
Overvalued
Consensus target
$85.79 -17.9%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0
Top-level breakdown
Valuation: PE Ratio: 33.82PEG Ratio: -DE Ratio: -
Free Cash Flow: -PB Ratio: -PS Ratio: -Dividend: $0.63
Analyst coverage

Blended analyst consensus & targets.

4 PANELS · UPDATED 07.27.26
Analyst consensus RATING · SCORE · PANELS · ANALYSTS
Rating Blended score Panels Analysts
Buy 4.2 4 106
Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE
Coverage Low Mean Median High Upside
All panels $92.00 $118.95 $119.00 $143.00 +13.8%
Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL
Coverage SB B H S SS
All panels 7 35 10 1 0
Rating trend CURRENT VS 1M / 2M / 3M
Period Rating Avg Analysts
Current Strong Buy 4.45 29
1 Mo Ago Strong Buy 4.43 28
2 Mo Ago Strong Buy 4.43 28
3 Mo Ago Strong Buy 4.43 28
Most recent analyst action LATEST DESK ACTION
Date
7/23/2026
Firm
Weiss Ratings
Action
Downgrade
Rating
Hold (C-) ➝ Sell (D+)
Target
—
Related links
Financials

Full financial snapshot.

UPDATED 07.27.26
Quote snapshot 15 FIELDS
Prev Close
$103.06
Open
$104.09
Day Low
$103.38
Day High
$105.85
Bid
$104.71
Ask
$105.00
52W Low
$81.97
52W High
$137.49
50D Avg
$91.28
200D Avg
$109.02
Volume
9.1M
Avg Vol
13.3M
10D Avg Vol
15.0M
52W Change
-18.43%
S&P 52W Change
16.00%
Valuation ratios 10 FIELDS
P/E (TTM)
33.82
P/E (Fwd)
17.23
PEG (Fwd)
2.08
P/S
3.91
P/B
3.50
Book Value
$29.89
EV/Revenue
4.50
EV/EBITDA
17.65
Mkt Cap
182B
Enterprise Val
209.48B
Profitability & returns 6 FIELDS
Profit Margin
11.65%
Gross Margin
56.77%
Operating Margin
14.15%
EBITDA Margin
25.47%
Return on Assets
—
Return on Equity
—
Growth 3 FIELDS
Revenue Growth (YoY)
13.00%
Earnings Growth (YoY)
-47.50%
Earnings Growth (Q)
-47.80%
Balance sheet & cash flow 11 FIELDS
Total Revenue
46.58B
EBITDA
11.87B
Total Cash
7.3B
Total Debt
34.14B
Cash / Share
$4.19
Revenue / Share
$26.79
Free Cash Flow
7.38B
Operating CF
9.46B
Debt / Equity
64.77
Current Ratio
—
Quick Ratio
—
Dividend 5 FIELDS
Fwd Dividend
2.52 (2.45%)
Dividend Yield
2.45%
Payout Ratio
78.96%
5Y Avg Yield
1.82%
Ex-Div Date
2026-07-15
Share statistics 7 FIELDS
Shares Out
1.74B
Float
1.73B
Shares Short
24.85M
% Short of Float
1.59%
Short Ratio
1.83
% Held Insiders
0.49%
% Held Institutions
82.52%
Calendar & events 5 FIELDS
Next Earnings
2026-10-14
Fiscal Year End
2025-12-31
Most Recent Qtr
2026-06-30
Last Split
10000:4798
Split Date
2013-01-02
Company 2 FIELDS
Industry
Medical Devices
Employees
122,000